How To Overcome Clinical Disparities in Women with Chronic Kidney Disease (CKD)

Cardiovascular Mortality Risk Triples in T2D Patients with CKD Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) face heightened risks of cardiovascular and renal morbidity and mortality. Diabetic kidney disease (DKD) is the leading cause of dialysis-dependent chronic kidney disease and end-stage renal disease (ESRD) in the US and most countries.   According to the […]

5 Keys to Patient Education on GLP-1 RAs for Weight Loss

As ‘magic’ weight loss drugs capture public attention, you’ve likely seen an uptick in patients asking about GLP-1 RAs for weight loss. As your go-to partner for cardiometabolic risk reduction research, industry news, and practical strategies, we’ve created this highly practical guide to help you educate patients on safe access to GLP-1 RAs for weight […]

Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care

The not-so-sudden rise of weight loss ”wonder” drugs for T2D and obesity This World Obesity Day, March 4, 2024, weight loss drugs dominate discussions and raise new questions for clinicians. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have been used to treat type 2 diabetes (T2D) since the approval of Byetta (exenatide) in 2005. In the […]

The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care

The High Cost of Insulin: Bridging Gaps on Path to Affordable Care

Why are insulin prices so high? Short history from development to today’s price hikes Doctors Frederick Banting and Charles Best successfully isolated the hormone insulin just over 100 years ago, dramatically changing the lives of those with diabetes. When Nobel Prize Winner Banting discovered insulin, out of ethical consideration, he refused to put his name […]

Kidney Week 2023: Top Ten Takeaways

More than 12,000 attendees flocked to Philadelphia, Pennsylvania, on Nov. 2-5, 2023, to gain perspective on the latest advances in the management of glomerular disease. Kidney Week 2023 not only served as a platform for the latest news and updates in the field but also marked the final meeting of the year for practitioners in […]

Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs

Cardiometabolic health education leader CMHC announced that its digital education has been streamlined into 12 hubs organized by therapeutic or clinical topics for focused learning The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization. A vast collection of webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and […]

Alcohol and Tobacco Use: Diabetes Risk Factors Increasing in Prevalence

Despite continuous therapeutic innovations and management strategies, diabetes remains a major public health concern affecting an estimated 34 million Americans with an ever-increasing prevalence. Of the factors known to influence diabetes risk and development, tobacco use is an established cause of type 2 diabetes and there is a growing consensus that alcohol use contributes to the […]

Coffee, Green Tea, and Type 2 Diabetes Mortality Rates

Previous studies in the general population suggest that both green tea and coffee can contribute to health benefits, preventing chronic diseases, and even reducing mortality risks. However, limited evidence is currently available regarding the consumption of these beverages on patients with type 2 diabetes mellitus. There is significant potential for reduced all-cause mortality associated with […]

Understanding (and avoiding!) Microvascular and Macrovascular Complications

The blood vessels in your body are like the pipes running through your home. The whole vascular system is the pipeline through which blood travels, carrying oxygen and nutrients to tissues. In turn, waste is moved away from the tissues to be metabolized and eliminated by the liver and kidneys. Blood vessels are bigger at their […]


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.